Thomas Havenith
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
-
- HIV Research and Treatment
Papers in
-
- Poisoning and overdose treatments 4
- HIV-related health complications and treatments 1
-
- Hepatitis C virus research 2
- Co-authors
- Alfred D. van het Schip (1 shared paper)Jan‐Henry Seppenwoolde (1 shared paper)Clemens Bos (1 shared paper)J. Frank W. Nijsen (1 shared paper)Chris J.G. Bakker (1 shared paper)K. Hoogtanders (2 shared papers)Rob E. Aarnoutse (2 shared papers)Luuk B. Hilbrands (2 shared papers)
- Journals
- Clinical Infectious Diseases (2 papers)The Lancet HIV (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)Journal of Hepatology (1 paper)BMC Pharmacology and Toxicology (1 paper)
- Partner nations
- NetherlandsGermanyBelgium
In The Last Decade
Thomas Havenith
18 papers receiving 348 citations
Peers
Comparison fields: 5 of 45
- Hepatology 144
- Virology 28
- Transplantation 15
- Infectious Diseases 55
- Radiology, Nuclear Medicine and Imaging 48
Countries citing papers authored by Thomas Havenith
This map shows the geographic impact of Thomas Havenith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Havenith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Havenith more than expected).
Fields of papers citing papers by Thomas Havenith
This network shows the impact of papers produced by Thomas Havenith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Havenith. The network helps show where Thomas Havenith may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Havenith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 60 | |
| 2 | 2020 | 59 | |
| 3 | 2017 | 57 | |
| 4 | 2022 | 48 | |
| 5 | 2015 | 26 | |
| 6 | 2014 | 23 | |
| 7 | 2024 | 20 | |
| 8 | 2023 | 14 | |
| 9 | 2019 | 11 | |
| 10 | 2014 | 7 | |
| 11 | 2017 | 7 | |
| 12 | 2024 | 7 | |
| 13 | 2017 | 4 | |
| 14 | [A patient with a life-threatening disulfiram-ethanol reaction]. | 2013 | 3 |
| 15 | 2018 | 3 | |
| 16 | 2021 | 3 | |
| 17 | 2020 | 1 | |
| 18 | 2025 | 1 |
About Thomas Havenith
Thomas Havenith is a scholar working on Emergency Medicine, Hepatology, Infectious Diseases, Transplantation and Pharmacology, having authored 18 papers that have together received 354 indexed citations. Recurring topics across this work include Poisoning and overdose treatments (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), HIV/AIDS Research and Interventions (2 papers), Hepatitis C virus research (2 papers), HIV/AIDS drug development and treatment (2 papers), HIV-related health complications and treatments (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Hepatology (144 citations), Virology (28 citations), Transplantation (15 citations), Infectious Diseases (55 citations) and Radiology, Nuclear Medicine and Imaging (48 citations). Thomas Havenith has collaborated with scholars based in Netherlands, Germany and Belgium. Frequent co-authors include Alfred D. van het Schip, Jan‐Henry Seppenwoolde, Clemens Bos, J. Frank W. Nijsen, Chris J.G. Bakker, K. Hoogtanders, Rob E. Aarnoutse, Luuk B. Hilbrands, Cees Neef and Rogier Donders. Their work appears in journals such as Clinical Infectious Diseases, The Lancet HIV, Cancer Chemotherapy and Pharmacology, Journal of Hepatology and BMC Pharmacology and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.